Morgan Hack, APRN
Family · Bardstown, KYNPI 1194598508
Payments from drug & device makers
Across 88 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$376
- Johnson & Johnson$194
- E.r. Squibb & Sons, L.L.C.$164
- AbbVie$136
- Takeda Pharmaceuticals U.S.A., Inc.$122
- Genentech USA, Inc.$101
- plus $1K from 30 others
What the payments were for
- Food & beverage$1,94688%
- Education$27612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $376 |
| Johnson & Johnson | 7 | $194 |
| E.r. Squibb & Sons, L.L.C. | 8 | $164 |
| AbbVie | 8 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $122 |
| Genentech USA, Inc. | 5 | $101 |
| Seagen Inc. | 1 | $99 |
| Merck | 5 | $94 |
| Jazz Pharmaceuticals Inc. | 1 | $83 |
| Incyte Corporation | 3 | $72 |
| Novartis | 3 | $63 |
| Caris MPI, Inc. | 1 | $63 |
| Bristol Myers Squibb | 3 | $56 |
| Sanofi | 2 | $54 |
| Genmab U.S., Inc. | 2 | $45 |
| Gilead | 2 | $41 |
| GSK | 2 | $39 |
| Iovance Biotherapeutics, Inc. | 1 | $34 |
| Array Biopharma Inc | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Karyopharm Therapeutics Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Bayer | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $22 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $17 |
| Novocure Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Stemline Therapeutics Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Eisai Inc. | 1 | $14 |
How this compares
$2,222 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 15 | $13,817 |
| Sertraline Hcl | 55 | $2,220 |
| Ropinirole Hcl | 53 | $947 |
| Divalproex Sodium | 12 | $842 |
| Buspirone Hcl | 26 | $771 |
| Potassium Chloride | 22 | $694 |
| Mirtazapine | 16 | $639 |
| Ciclopirox | 12 | $504 |
| Levothyroxine Sodium | 47 | $495 |
| Fluticasone Propionate | 20 | $421 |
| Ondansetron OdtOndansetron | 20 | $405 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $314 |
| Lactulose | 13 | $276 |
| Furosemide | 32 | $242 |
| Lisinopril | 13 | $228 |
Paid to pharmacies, not to this prescriber.
Other family in Bardstown
- Dale VincentBardstown$28K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.